# Collagen Joint Stiffness Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/collagen-joint-stiffness-meta-analysis-evidence-review
Category: evidence-review
Summary: Collagen Joint Stiffness Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-07-23
Reviewed by: Migaku Evidence Review
# Collagen Joint Stiffness Meta-analysis: What the Evidence Says

## Quick Answer

Collagen Joint Stiffness Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Hormonal Stabilization of the Bone-Metabolic Environment: Implications for Anterior Cruciate Ligament Integrity and Bone-Graft Integration | preclinical study | 4 | 2026-05-01 | 10.11005/jbm.26.1022 |
| Diabetes-Related Metabolic Osteoarthritis: Advanced Glycation&#8211;Collagen Axis, Cartilage Stiffening, and Biomaterials-Based Therapeutic Strategies | preclinical study | 4 | 2026-05-29 | 10.2147/IJN.S610406 |

## What The Sources Report

- The ACL rupture might be the best investigated of all sex associated sport injuries. [Koren Andro (2026); evidence level 4]
- Several reviews and meta-analyses have since concluded that there is a decreased relative risk of an ACL tear in the luteal phase and that female athletes are more predisposed to ACL ruptures during the preovulatory phase of the menstrual cycle. [Koren Andro (2026); evidence level 4]
- "Diabetes-related OA" refers to OA discussed in the context of diabetes-associated hyperglycemia, insulin resistance, carbonyl stress, AGE accumulation, and inflammatory-matrix alterations. [Li Jiayao (2026); evidence level 4]
- "Metabolic OA" is a broader phenotype involving systemic metabolic dysfunction, including but not limited to diabetes, obesity, dyslipidemia, adipokine imbalance, and low-grade inflammation.,"Obesity-associated OA" emphasizes the combined contribution of excess mechanical loading and adipose-driven inflammatory/metabolic signaling. [Li Jiayao (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For collagen joint stiffness meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Koren Andro (2026). Hormonal Stabilization of the Bone-Metabolic Environment: Implications for Anterior Cruciate Ligament Integrity and Bone-Graft Integration. DOI: 10.11005/jbm.26.1022. PMCID: PMC13284591. PMID: 42316443. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Acces.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13284591/
- Li Jiayao (2026). Diabetes-Related Metabolic Osteoarthritis: Advanced Glycation&#8211;Collagen Axis, Cartilage Stiffening, and Biomaterials-Based Therapeutic Strategies. DOI: 10.2147/IJN.S610406. PMCID: PMC13228870. PMID: 42239648. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13228870/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.